Market Research Report
Global Polymerase Chain Reaction Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||837254|
|Published||Content info||120 Pages
Delivery time: 2-3 business days
|Global Polymerase Chain Reaction Market Forecast 2019-2027|
|Published: May 13, 2019||Content info: 120 Pages||
Global polymerase chain reaction market refers to the method that produces abundant copies of a target DNA region in vitro. This chain reaction depends on a thermostable DNA polymerase called TAQ polymerase, which is extracted from Thermus aquaticus and as the name suggests, they live in hot springs and hydrothermal vents.
Global polymerase chain reaction market generated a revenue of $XX billion in 2018 & is projected to reach $13,644 million by 2027, at a CAGR of 6.19% during the forecasting years of 2019-2027. The base year considered for the study is 2018 & the estimated period is between 2019 & 2027.
Global polymerase chain reaction market is primarily driven by increasing prevalence of infectious diseases and the growing geriatric population. The increasing investments by the key players coupled with rapid changes in technology are the prime factors which are fueling the growth of the market.
With the growing acceptance of polymerase chain reaction techniques, the global market is also facing some challenges. The inability of the conventional PCR technique to target complex endpoint sequences is limiting the growth of the PCR in the forecast period. The availability of alternative technologies for DNA sequencing is also probing as a challenge to the market in the coming years. Moreover, the high cost of instruments and the high cost of labor is further obstructing the growth of the global market.
Also, the increasing collaborations and mergers between key players for launching innovative products with more efficient polymerase chain reaction techniques will further fuel the market growth in the future.
Report scope of the global polymerase chain reaction market covers segmentation by several regions, namely, North America, Asia Pacific, Europe and the remaining countries collectively forming the Rest of World regional segment.
The North America polymerase chain reaction market is rising rapidly owing to the rising occurrence rate of infectious and chronic diseases such as the likes of HIV/AIDS, hepatitis, and cancer in concurrence with an increasing number of R&D activities by biotechnological & pharmaceutical companies in the region. The increasing laboratory usage for PCR in the region coupled with new product developments in the region is boosting the growth of the North America polymerase chain reaction market.
Becton Dickinson Biosciences Systems and Reagents Inc., Abbott Laboratories, Qiagen N.V., Biomerieux SA, Fluidigm Corporation, Danaher Corporation, Siemens Healthineers, MDXhealth Corporation, Agilent Technologies Inc., Pacific Biosciences of California, Inc., Nano Biosys Inc., Bio-Rad Technologies Inc., Tahara Bio Inc., Thermo Fisher Scientific Inc., and F. Hoffman La Roche Ltd. are the major companies operating in the market which have been thoroughly outlined in the report.